您使用提示模式 关闭

KURE - KraneShares MSCI All China Health Care Index ETF (USD) (US5007678353)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

使用 Cbonds Watchlist 查找、保存和跟踪投资工具

有了 Cbonds Watchlist，您可以随时了解投资信息，做出明智决策！

Watchlist
需要 访问

全选 清除所有
 
(%)
US5007678353
KURE ISIN
交易所交易基金 (ETF)
基金类型
CICC
提供商
19,06 USD
每股资产净值 | 2026-08-26
2018-01-31
成立日期
1 每年的次数
股息的支付
CEOJLS
CFI
KURE
代码
Formed
Status
Equity
投资项目
Healthcare
部门
China
地区分布
MSCI China All Shares Health Care 10/40 Index
基准
0.65 %
总成本比率
110,56 百万 USD
基金资产总量 | 2026-08-26
110,56 百万 USD
股票类资产 | 2026-08-26
否
UCITS

收益率 在 2026-08-27, NYSE Arca

  • YTD
    -7,99 %
  • 1M
    -10,97 %
  • 3M
    -12,52 %
  • 6M
    -14,27 %
  • 1Y
    8,04 %
  • 3Y
    -13,2 %
  • 5Y
    -60,63 %
  • 10Y
    -
按交换价格计算，包括收入支付

最新数据在
添加比较项目
从
至
ADD-IN
Cbonds 加载项 API
债券数据 API

报价 (KURE)

探索最全面的数据库

1 000 000

债券

100 000

股票

175 910

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件
请求访问

价格动态的变化

KURE profile

The KraneShares MSCI All China Health Care Index ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in China. The CICC fund’s base currency is USD and the share class was registered 31.01.2018 with unique ISIN - US5007678353. Main exchange is NYSE Arca and ticker symbol is KURE. The total expense ratio is 0.65%. The KraneShares MSCI All China Health Care Index ETF (USD) pays dividends 1 time(s) per year.

结构 KURE 在 2026-08-26

下载结构至 Excel 文档
证券 值
INNOVENT BIOLOGICS INC 9,76%
BEONE MEDICINES LTD-H 9,1%
WUXI BIOLOGICS CAYMAN INC 7,43%
WUXI APPTEC CO LTD-A 5,5%
SHENZHEN MINDRAY BIO-MEDIC-A 4,41%
SINO BIOPHARMACEUTICAL 3,92%
AKESO INC 3,64%
CSPC PHARMACEUTICAL GROUP LT 3,63%
JIANGSU HENGRUI PHARMACEUT-A 3,61%
WUXI APPTEC CO LTD-H 3,28%
GENSCRIPT BIOTECH CORP 2,94%
HANSOH PHARMACEUTICAL GROUP 2,73%
3SBIO INC 2,31%
YUNNAN BAIYAO GROUP CO LTD-A 2,17%
SHANGHAI UNITED IMAGING HE-A 2,11%
SICHUAN KELUN-BIOTECH BIOP-H 2,01%
AIER EYE HOSPITAL GROUP CO-A 1,93%
ZHANGZHOU PIENTZEHUANG PHA-A 1,87%
SICHUAN KELUN PHARMACEUTIC-A 1,69%
SICHUAN BIOKIN PHARMACEUTI-A 1,62%
PHARMARON BEIJING CO LTD-A 1,58%
Cash 1,53%
SINOPHARM GROUP CO-H 1,5%
HAISCO PHARMACEUTICAL GROU-A 1,38%
SHANGHAI ALLIST PHARMACEUT-A 1,22%
WUXI XDC CAYMAN INC 1,22%
SHANGHAI FOSUN PHARMACEUTI-A 1,17%
HUADONG MEDICINE CO LTD-A 1,16%
SHANGHAI PHARMACEUTICALS-A 1,11%
REMEGEN CO LTD-H 1,04%
REMEGEN CO LTD-A 1,04%
CHINA RESOURCES SANJIU MED-A 0,99%
SHENZHEN NEW INDUSTRIES BI-A 0,98%
XTALPI HOLDINGS LTD 0,89%
CSPC INNOVATION PHARMACEUT-A 0,88%
SHENZHEN SALUBRIS PHARM-A 0,86%
APT MEDICAL INC-A 0,85%
CHONGQING ZHIFEI BIOLOGICA-A 0,82%
BEIJING TONG REN TANG CO-A 0,81%
LEGEND BIOTECH CORP-ADR 0,81%
SHANGHAI RAAS BLOOD PRODUC-A 0,8%
CHANGCHUN HIGH-TECH INDUST-A 0,78%
IMEIK TECHNOLOGY DEVELOPME-A 0,69%
BEIJING WANTAI BIOLOGICAL-A 0,66%
HEBEI CHANGSHAN BIOCHEMICA-A 0,53%
HANGZHOU TIGERMED CONSULTI-A 0,45%
KANGMEI PHARMA - RIGHTS O 0%
HONG KONG DOLLAR 0%
CHINESE YUAN RENMINBI -1,45%
显示所有 隐藏
Other - %

其他 ETF 和基金提供商

相关 ETF 和基金

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    资产净值
    {{ item.expense_ratio }}
    总成本比率
你必须 注册 才能获得访问权